This inventor holds 5 USPTO granted patents and 5 published patent applications. Top assignees: Kt Corporation, Neuracle Science Co., Ltd.. Active years: 2015-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2023
Title: **Inventor Spotlight: Shin-Hyuk Kang**
Introduction
Shin-Hyuk Kang, an innovative inventor based in Seoul, South Korea, has made significant strides in the fields of biotechnology and application control, boasting a portfolio of five patents. His work is characterized by a commitment to addressing pressing health challenges and improving technology functionality.
Latest Patents
One of Shin-Hyuk Kang's latest patents involves the use of anti-FAM19A5 antibodies for treating cancers. This groundbreaking disclosure centers on the pharmaceutical application of antagonists that specifically bind to FAM19A5. The goal is to promote blood vessel normalization, aimed at enhancing treatment efficacy for cancer patients.
Additionally, he has developed a patent titled "Controlling applications according to connection state and execution condition." This innovation focuses on optimizing application execution in user equipment by managing the execution conditions based on the connection status of the device. Such a controlled approach aims to enhance user experience.
Career Highlights
Shin-Hyuk Kang has held key positions in notable companies, including KT Corporation and Neuracle Science Co., Ltd. His experiences in these organizations have provided him with a robust foundation in technological innovation and patent development. Through his time at these companies, he has been instrumental in advancing research and development efforts.
Collaborations
Throughout his career, Shin-Hyuk Kang has collaborated with esteemed colleagues such as Jung-Wook Lee and You-Jin Kang. These partnerships have fostered a creative environment conducive to innovation and have led to successful patent applications in their respective fields.
Conclusion
Shin-Hyuk Kang's contributions to biotechnology and application control reflect his dedication to improving human health and technology functionality. His impressive patent portfolio underscores the impact of his work and the potential to inspire future innovations in these critical areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile